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Summary  
The role of the host extracellular matrix (ECM) in infection tends to be neglected. However, 
the complex interactions between invading pathogens, host tissues and immune cells occur 
in the context of the ECM. On the pathogen side, a variety of surface and secreted 
molecules, including microbial surface components recognizing adhesive matrix molecules 
(MSCRAMM) and tissue degrading enzymes, are employed that interact with different ECM 
proteins in order to effectively establish an infection at specific sites. Microbial pathogens 
can also hijack or misuse host proteolytic systems to modify the ECM, evade immune 
responses or process biologically active molecules such as cell surface receptors and 
cytokines that direct cell behaviour and immune defense. On the host side, the ECM 
composition and three-dimensional ultrastructure undergo significant modifications, which 
have a profound impact on the specific signals that the ECM conveys to immune cells at the 
forefront of infection. Unexpectedly, activated immune cells participate in the remodelling of 
the local ECM by synthesizing ECM glycoproteins, proteoglycans and collagen molecules. 
The close interplay between the ECM and the innate immune response to microbial 
pathogens ultimately affects the outcome of infection. This review explores and discusses 
recent data that implicates an active role for the ECM in the immune response to infection, 
encompassing antimicrobial activities, microbial recognition, macrophage activation, 
phagocytosis, leukocyte population balance and transcriptional and post-transcriptional 
regulation of inflammatory networks, and may foster novel antimicrobial approaches. 
 
Introduction 
To successfully establish an infectious disease, most pathogenic bacteria adhere to the host, 
invade underlying tissues, multiply and grow while evading or overcoming host immune 
defences (1). The underlying host-pathogen interactions are remarkably specific and involve 
a variety of substrates within the host. The interactions of pathogens with eukaryotic cells 
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has been intensively studied in microbiology, immunology, cell biology, genetics and ecology 
research. Less attention has been given to the host extracellular matrix (ECM). However, the 
individual components of the ECM are substrates to which pathogens can directly bind to or 
degrade, facilitating adhesion and penetration into the host; evidence for this started to 
accumulate 40 years ago (2, 3). Furthermore, the ECM is a fundamental component of the 
host cellular microenvironment where most of the events leading to infection, disease and 
tissue repair take place and is also a reservoir of diverse and tissue-specific signals that feed 
into immunological pathways (4, 5). Recently, evidence has emerged that the ECM conveys 
specific signals to cells thereby modulating essential immune functions, immune cell 
migration into and within infected tissues and immune cell activation, proliferation and 
differentiation. Moreover, the ECM composition undergoes significant alterations during 
infection and, notably, specific immune cell types appear to contribute to that. Thus, 
regulatory circuits closely link the ECM and the immune system. 
 
Important questions to emerge from these studies include i) does the ECM play an active 
role in infection rather than simply providing a scaffold for bacterial adhesion or being a 
barrier to breach; ii) which ECM-pathogen interactions significantly impact the ability of 
pathogens to colonise and invade host tissues, and/or bypass host defences, and influence 
how host cells respond to pathogens; and iii) can we interfere with these interactions to 
develop new antimicrobial strategies or improve existing ones. Here, we briefly review the 
ECM and its interactions with microbial pathogens, and discuss the evidence of a direct 
implication of the ECM in the immune response to infection.  
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The ECM: an immunological perspective 
Most infections and the resulting immune responses are tissue-specific. Each tissue has 
distinct ECM signatures which arise from complex and dynamic combinations of up to ~300 
different proteins in varying concentrations and geometries within the three-dimensional 
extracellular space. This ever increasing number of proteins which contribute to matrices 
(the “matrisome”) include approximately 43 collagen subunits, 36 proteoglycans and 200 
glycoproteins (6). ECM molecular multiplicity and complexity are amplified by 
posttranslational modifications, which can unveil cryptic epitopes or generate new ones 
capable of triggering immune reactions, and alternative splicing, which generates several 
isoforms with distinct functions (7, 8). For instance, laminins 4 and 5 isoforms in 
basement membranes contribute to immune cell subtype selectivity during leukocyte 
recruitment to sites of inflammation (9, 10). 
 
Interstitial ECMs, loose fibril-like matrices that fill the tissue stroma, and basement 
membranes, laminar sheets that anchor cell layers to underlying tissues, are basic forms of 
ECM. Additionally, specialised reticular fibre networks combining features of these two ECM 
structures are found in secondary lymphoid organs (11, 12).  
 
The ECM is a highly dynamic yet strictly regulated tissue component. Its composition and 
normal function are determined and maintained by a fine balance between ECM synthesis, 
orchestrated by cytokines such as transforming growth factor- (TGF-), and turnover, 
accomplished by matrix metalloproteinases (MMPs), a disintegrin and metalloproteinases 
(ADAMs) and a disintegrin and metalloproteinases with thrombospondin motifs (ADAMTSs), 
whose activity is controlled by tissue inhibitors of metalloproteinases (TIMPs) (13). During 
injury and infection, these enzymes are produced by activated immune cells such as 
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monocytes/macrophages and promote immune cell migration into sites of infection and 
tissue damage and affect their ability to mount inflammatory responses (14). 
 
The central dogma of matrix biology describes how the ECM provides structural support for 
cells and contributes to the unique structure of a tissue. However, this is only one function of 
the ECM. Host immune responses are carried out in the context of the ECM therefore when 
immune cells contact the ECM, they receive vital instructions for their survival, proliferation, 
differentiation and activation, in addition to support for adhesion and guidance for migration. 
Several mechanisms are responsible for the communication between the ECM and cells. 
One such mechanism is signalling through cell surface adhesion molecules and receptors, 
including integrins and discoidin-domain receptors (DDRs) (reviewed in (15, 16)). Others 
involve binding, storage, activation and release of secreted molecules with potent 
immunomodulatory activity, including cytokines, chemokines and growth factors (17, 18). For 
instance, TGF- has been shown in vitro and in vivo to affect activation, proliferation and 
differentiation of most immune cell types, modulating nearly all stages of the immune 
response (19). Moreover, bioactive ECM fragments generated by tissue destruction (e.g. 
hyaluronan and heparan sulfate oligosaccharides) and ECM molecules whose expression is 
specifically induced upon tissue injury (e.g. fibronectin isoforms containing extra domain A 
(FN-EDA), versican and biglycan) promote inflammation by inducing pro-inflammatory gene 
expression or exhibiting chemoattractant properties (reviewed in (20, 21)). These molecules 
form a class of endogenous damage-associated molecular patterns (DAMPs) (22), which, by 
activating pattern recognition receptors (PRRs) such as toll-like receptors (TLRs) in immune 
cells (e.g. macrophages and dendritic cells) and non-immune cells (e.g. fibroblasts and 
epithelial cells) alert the immune system to tissue damage and infection that initiates 
pathogen clearance, but also tissue repair (23). Thus, the ECM and the immune system are 
intertwined: signals from the ECM help coordinate immune responses and, in turn, immune 
cells promote ECM repair and regeneration through the release of cytokines such as tumour 
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necrosis factor (TNF), interferon- (IFN-) and TGF-, which regulate the expression of many 
ECM molecules.  
 
ECM-pathogen interactions 
 
A tale of adhesion and colonization of the host 
Tissue adherence represents the first essential mechanism that bacteria adopt to colonize 
the host. Failure to do so results in the organism being removed by physiological cleansing 
systems at sites of entry. The surface of host cells and the ECM are negatively charged and 
microbes employ a number of physico-chemical forces to overcome these repulsive forces 
and establish interactions between a microbial ligand or “adhesin” and a complementary 
molecule or “receptor” on the host tissue. These interactions are highly specific, contributing 
to tissue tropism, species specificity and genetic specificity within a species. Bacterial 
adhesins are components of capsules, cell walls, pili or fimbriae, and those that bind to ECM 
components are called microbial surface components recognizing adhesive matrix 
molecules (MSCRAMM). Host receptors are usually glycoproteins found on the cell 
membrane and ECM components (24).  
 
The binding of microbial pathogens to specific ECM proteins has been extensively reviewed 
elsewhere (1, 3, 25, 26) and will be briefly discussed here. The first report of a host ECM-
pathogen interaction was published in 1978 by Kuusela et al. who studied the binding of 
Staphylococcus aureus to fibronectin (2) and, a few years later, revealed two separate 
binding sites on fibronectin, in the N- and C-terminus respectively (27). Other groups further 
characterised the interaction of this ubiquitous and promiscuous ECM glycoprotein with S. 
aureus and Streptococcus pyogenes, which has a remarkably large number of fibronectin 
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binding adhesins (28-33). Several other ECM proteins such as laminin, collagen, heparan 
and chondroitin sulphate, vitronectin, thrombospondin, elastin, bone sialoprotein and 
tenascin-C, have since been implicated in specific interactions with pathogenic bacteria ((26, 
34); Table 1).  
 
Early studies were mostly limited by the use of binding assays, involving bacterial cells or 
recombinant adhesins and ECM molecules, and inhibition experiments to demonstrate these 
interactions. Cutting-edge technologies, including live cell imaging and particle-tracking 
methods, have now started to reveal the implications of these interactions in pathogenesis. 
For example, Niddam et al. showed that the Lyme disease spirochete Borrelia burgdorferi 
exploits fibronectin to interact with vascular surfaces under physiological shear stress. 
Specifically, it recruits and induces polymerization of soluble plasma fibronectin that 
strengthens and stabilizes bacterial interactions with endothelia by a catch-bond mechanism 
(35).  
 
Breaking down barriers to invade the host 
Having colonized the host, most pathogens need to invade tissues in order to cause 
disease. This requires the breakdown of primary and/or secondary defences of the host, 
involving the crossing of basement membranes and interstitial matrices. Pathogens have 
developed distinct ways to modify the ECM (1, 36).    They can directly degrade ECM 
components using “invasins” or bacterial tissue degrading enzymes such as hyaluronidases 
and collagenases, causing local tissue damage. Specific examples of these interactions are 
reported in Table 2 and reviewed elsewhere (26, 36). Degradation of the ECM not only 
facilitates the spread of pathogens, but can also favour tissue necrosis, bacterial toxin 
diffusion and host cell adhesion, migration and survival.    Pathogens can also indirectly 
modify the ECM by altering the synthesis and turnover of ECM components by host cells in 
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response to their presence (discussed later in this review).   Moreover, pathogens can hijack 
or misuse host proteolytic systems. For instance, S. aureus (37), Haemophilus influenzae 
(38) and Pseudomonas aeruginosa (39) among other common pathogenic bacteria, 
manipulate the plasminogen-plasmin system thereby degrading laminin and fibronectin and 
activating MMP zymogens that not only degrade all types of ECM proteins, but also process 
many biologically active molecules (e.g. cell surface receptors and cytokines) that direct cell 
behaviour and host defence.  
 
Strategies to evade the host immune response? 
Although numerous pathogens undoubtedly exploit ECM components and ECM-associated 
molecules to adhere to and degrade tissues for efficient host colonization and invasion, it is 
not always clear whether pathogens interact with these ECM molecules also to evade 
immune responses. For instance, B. burgdorferi can avoid antibody-mediated clearance and 
this may be partly explained by its specific interaction with decorin (36). The H. influenzae 
surface protein E (PE) binds to plasminogen, which is converted to plasmin, and uses 
plasmin for complement evasion and innate immune escape (37). Several other pathogenic 
bacteria take advantage of the host plasminogen system to facilitate their own spread an 
invasion through tissues (40, 41). Notably, H. pylori benefits the complement regulatory 
property and the plasminogen binding ability of vitronectin to protect itself from innate 
immune responses (42). Furthermore, Group B Streptococci (GBS) and other Gram-positive 
bacteria secrete hyaluronidases, whose activity allows immune evasion besides tissue 
invasion. Specifically, their hyaluronidases process pro-inflammatory hyaluronan fragments 
into disaccharides, which block TLR2/4 signalling triggered by host-derived hyaluronan 
fragments and pathogenic ligands, including lipopolysaccharide (LPS), thereby evading 
immune detection (43).  
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Altered ECM dynamics in infection and its implications 
The ECM undergoes significant alterations upon infection that promote or inhibit the 
establishment of infection and the host response to it. Below is an overview of the changes 
in ECM synthesis, degradation and post-translational modification during infection and a 
discussion of their implications in pathogenesis. 
 
ECM synthesis and deposition 
Signal transduction pathways activated upon pathogen entry and recognition and by 
mediators of inflammation and tissue repair during infection all contribute to ECM synthesis 
and deposition. This involves structural ECM proteins (e.g. collagens, laminins and 
proteoglycans) as well as non-structural ECM components termed ‘matricellular proteins’, 
which are normally absent or scarcely expressed in healthy tissues (e.g. osteopontin, 
thrombospondins, galectins, tenascins, etc.). For instance, rhinovirus activates TLR3 and 
TLR7/8 signalling in airway smooth muscle (ASM) cells that leads to increased deposition of 
fibronectin, perlecan and collagen IV, contributing to airway remodelling and facilitating the 
migration of ASM cells to the infection site (44). IL-33 signalling induced by S. aureus 
enhances fibronectin and collagen IIIa expression and deposition, accelerating wound repair 
(45).    Systems biology approaches elucidating the ECM interactome network regulated by 
Trypanosoma cruzi and its gp83 ligand, which mediates trypanosome attachment and entry, 
have shown that activation of gp83 receptors in the cell via ERK1/2 results in upregulation of 
laminin -1 and thrombospondin expression to facilitate trypomastigotes recruitment, 
enhancing cellular infection (46). In mice, Citrobacter rodentium infection induces 
osteopontin and fibronectin expression through integrin-linked kinase activation, facilitating 
bacterial colonization of the intestine (47). High expression levels of osteopontin have also 
been shown to be induced in murine acute and chronic coxsackievirus (CV) B3-myocarditis 
together with those of MMP-3, TIMP1, urokinase-type plasminogen activator (uPA) and 
TGF-1 and, in turn, procollagen-1alpha mRNA expression and fibrosis. Accordingly, 
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osteopontin-null mice are protected from viral myocarditis and inhibition of osteopontin 
transcription by vitamin D decreases cardiac fibrosis in wild type animals (48). Viral 
myocarditis also results in upregulation of tenascin-C before immune cell infiltration occurs 
and until scar tissue is formed (49). Elevated tenascin-C levels have also been reported in 
patients with sepsis, parapneumonic infection, tuberculosis and S.aureus infection (50-54). 
Furthermore, the lungs of mice infected with gram-negative bacteria show accumulation of 
versican, a chondroitin sulfate proteoglycan with multiple cytokine, chemokine, adhesion 
molecule and growth factor binding domains, that is implicated in the innate immune 
response (55). Similarly, when primary human lung fibroblasts are treated with the viral 
mimetic Poly I:C, they deposit a higher-order structured ECM, rich in versican and 
hyaluronan, to which T-cells avidly adhere and cease migration, an effect reversed by 
hyaluronidase treatment or versican antibody during matrix formation (56). Importantly, 
besides expression levels, infection can also alter the spatial distribution of ECM 
components as it emerges from influenza-infected lungs, which show distinct regions that 
are enriched with either fibronectin or collagen (57). Thus, specific infectious diseases seem 
to generate distinct compositional changes of the ECM, inevitably influencing its biophysical 
structure and presentation of bioactive compounds that impact bacterial colonization and 
invasion, immune cell response and tissue repair.  
 
ECM degradation 
The catabolic machinery that breaks down and remodels the ECM is also altered upon 
infection, affecting the supportive, barrier and biological functions of the ECM. Tissue 
degrading enzymes such as MMPs play a crucial role in regulating immune cell recruitment: 
they cleave the basement membrane ECM; expose cryptic pro-migratory sites of ECM 
components (e.g. 2 chain of laminin 5); target non-ECM proteins such as adhesion 
molecules (e.g. E-cadherin); activate, deactivate or regulate the bioavailability of chemokines 
(e.g. MCP-1 and IL-8) and cytokines (e.g. IL-1 and TNF-); and shed cell surface receptors 
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associated with cell migration (e.g. CD44), modulating inflammation (reviewed in (58-60)).   
With the exception of neutrophils, tissue degrading enzymes are not stored, but require de 
novo synthesis that is strictly regulated and can be induced by pro-inflammatory cytokines 
(e.g. TNF- and IL-1) and also by bacterial products (e.g. LPS and chlamydial heat shock 
proteins) (61).  
 
Several pathogens, including Mycobacterium bovis, Mycobacterium tuberculosis, S. 
pyogenes and H. pylori, induce expression and activity of a number of MMPs, including 
MMP-1, MMP-2, MMP-7, MMP-9 and MMP-13 (62-64). In particular, the extensive 
production of MMP-2 and MMP-9 during mycobacteria infection is regulated by macrophage- 
and T-cell-derived cytokines and causes ECM breakdown. This may be necessary for cell 
recruitment and granuloma formation, both protective immune responses to mycobacteria. 
However, dysregulation of MMP production at late stages of the infection could contribute to 
tissue damage and, by compromising tissue integrity, may facilitate bacterial dissemination 
and persistence of infection (62).    Systemic E. coli infection, acute Lyme neuroborreliosis 
and pneumococcal meningitis can all lead to secretion of high amounts of MMP-9. In 
meningitis, MMP-9 has been suggested to contribute to blood-brain barrier destruction and 
neuronal injury (65-67). Similarly, gastrin-dependent induction of MMP-7 upon H. pylori 
infection has been implicated in the development of gastric cancer through the release of 
heparin-binding epidermal growth factor (EGF) (64). Chlamydia trachomatis, which causes 
trachoma and blindness, upregulates MMP-7, MMP-9, MMP-12 and TIMP-1 expression, 
while it downregulates MMP-10 and SPARC (secreted protein, acidic, cysteine-rich)-like 1, a 
matricellular protein that regulates decorin production and collagen assembly (68). In this 
study the expression pattern of these ECM modifying enzymes correlated with the clinical 
scarring grade and inflammation.    Interestingly, a dual function has been shown for MMP-
12 in viral myocarditis caused by coxsackievirus type B3. While intracellular MMP-12 causes 
IFN- secretion and host protection, extracellular MMP-12 cleaves the IFN- receptor 2 
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binding site of IFN-, preventing an uncontrolled immune response (69). In the same model 
of viral myocarditis, MMP-9 exerts a protective role by inactivating IFN-/. Indeed, MMP-9-
null mice display higher viral load, infiltration of CD3+ cells and tissue damage (70).  
However, murine MMP-9 can also enhance susceptibility to infection and increase morbidity 
and mortality.  This is the case of Francisella tularensis pulmonary infection where MMP-9 
generates pro-inflammatory ECM-derived peptides (i.e. Pro-Gly-Pro (PGP) peptide from 
collagen I), enhancing neutrophil infiltration to lungs (71).    
 
In addition to inducing MMP expression, pathogens can also activate pro-MMPs by secreting 
their own activating enzymes as in the case of P. aeruginosa, which activates pro-MMP-2 
using LasB, a thermolysin-like metalloprotease (39). The role of dysregulated tissue 
degrading enzymes, individually or in combination, is not well understood in every infectious 
disease. However, it is clear that the MMP/TIMP system changes the ECM composition and 
biophysics and its presentation of bioactive molecules, generating environmental cues that 
are detected and processed by immune cells into signalling events that direct their behaviour 
and response to infection. 
 
ECM post-translational modification 
Post-translational modifications (PTMs) add complexity to the ECM. Some are generated by 
proteolytic cleavage, while others by citrullination of arginine, glycosylation, cross-linking, 
hydroxylation of prolines, nitrosylation of tyrosines and aspartate isomerization (reviewed in 
(7)). Given the ability of pathogens to hijack host enzymes or secrete enzymes targeting host 
molecules, it is tempting to ask whether PTMs in the ECM are altered in infection. Indeed, 
the Porphyromonas gingivalis enzyme peptidylarginine deiminase (PAD) can convert 
arginine residues to citrulline in mammalian ECM proteins, including fibrinogen, collagen II, 
fibronectin and tenascin-C (72-76). While arginine is positively charged at neutral pH, 
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citrulline is uncharged, increasing protein hydrophobicity and, thus, altering protein 3D 
structure and function. Notably, P. gingivalis periodontal infection has been linked to 
rheumatoid arthritis, an autoimmune disease of the joints characterised by high levels of 
citrullinated proteins and anticitrullinated ECM protein antibodies (77). T. cruzi, the etiologic 
agent of Chagas disease, which features extensive inflammation and fibrosis of the heart, 
has been reported to increase the expression of lysyl oxidase (LOX) (78). This enzyme 
carries out cross-linking of collagen fibers thereby altering matrix stiffness, which has been 
linked to cancer metastasis (79). By irreversibly altering collagen structure and function, LOX 
has been proposed to cause dysfunction of cardiomyocytes and, in turn, of the heart in 
Chagas disease. Similarly, dengue virus infection has been shown to suppress the 
expression of cartilage associated protein (CRTAP), alongside the protein associated to tight 
junctions (PATJ). CRTAP associates with the proteoglycan leprecan, which has collagen 
prolyl 3-hydroxylase activity, and cyclophilin B in the endoplasmic reticulum. This trimeric 
complex is required for proline 3-hydroxylation of collagen and, thus, collagen assembly. As 
the levels of CRTAP mRNA negatively correlate with viral replication, the authors of the 
study have speculated that CRTAP, together with PATJ, restrict dengue infection by 
influencing cell-cell adhesion (80).  
 
While evidence supporting a link between specific PTMs of ECM proteins and disease such 
as arthritis and cancer is accumulating, the implications of altered PTMs of ECM 
components during infection are only beginning to emerge. For example, collagen fiber 
cross-linking mediated by LOX can significantly alter tissue structure and ECM mechanics. 
Mammoto et al. recently showed that LOX-dependent changes in ECM mechanics control 
vascular permeability and pulmonary oedema. In vivo, mouse lungs treated with LPS, which 
contribute to pulmonary oedema and acute respiratory distress syndrome in patients with 
sepsis (81), become much stiffer than non-treated lungs and exhibited enhanced vascular 
permeability. Increased LOX expression and LOX and LOX1 protein isoform activity control 
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alveolar architecture and vascular permeability, which are restored by LOX activity inhibition 
(82). 
 
Macrophages: not just destroyers of the ECM 
In bacterial and viral infection, activated macrophages (e.g. M(IFN), M(LPS)) have long 
been implicated in ECM destabilization and destruction through the secretion of tissue 
degrading enzymes, including MMP-9. Similarly, parasitic infections involve activated 
macrophages (i.e. M(IL-4)), which release proteases such as MMP-1 and MMP-12 (83). 
However, macrophages can also produce a number of ECM proteins. Increasing evidence of 
this and its implications are discussed below. 
 
Fibronectin is the first ECM glycoprotein reported to be produced by human macrophages 
and IFN-stimulated mouse peritoneal macrophages (84, 85). Moreover, bacterial 
components induce tenascin-C expression in human monocyte-derived and mouse bone-
marrow derived macrophages (53, 86). LPS from P. gingivalis induces thrombospondin-1 
production in THP-1 cells (87), while LPS from E. coli and IFN- upregulate galectin-1 and -
3, including 5 galectin-3 truncated forms, in primary human macrophages (88). In mice with 
viral myocarditis, macrophages infiltrating the heart are the main producers of osteopontin 
(48). Notably, in murine macrophages, LPS causes the formation of chromosomal loops in 
the osteopontin promoter by bridging NF-kB and AP-1 together, leading to osteopontin 
transcription (89), which is negatively regulated by GSK3b (90).     
 
Macrophage expression of proteoglycans has also been demonstrated. Treatment of bone 
marrow-derived and alveolar macrophages with E. coli LPS results in rapid induction of 
versican and hyaluronan synthase 1, and simultaneous inhibition of the major hyaluronan 
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degrading enzymes (hyaluronidases 1/2) (91). Serglycin, decorin and biglycan are also 
secreted by LPS-activated mouse peritoneal macrophages (92-94).    By using inhibition, 
chromatin immunoprecipitation and NF-kB reporter gene assays, some of these studies 
have demonstrated that pathogenic activation of the NF-kB signalling pathway downstream 
of TLR4 leads to ECM molecule transcription (86, 89, 93-95). Importantly, in the case of 
tenascin-C, biglycan and decorin, which can activate TLR4, this can promote autocrine loops 
of inflammation (86, 93, 94). Thus, the infected cellular microenvironment influences TLR 
function and, in turn, TLR activation affects the microenvironment.  
 
Intriguingly, there is mounting evidence that macrophages can synthesize collagen 
molecules. In Drosophila, phagocytes (hemocytes) produce functional collagen IV, which 
controls key signalling events in the germline stem cell niche (96). The first reports of 
collagen synthesis by mammalian macrophages were published in the 1990s. The first 
showed collagen I synthesis in mouse peritoneal macrophages and the second 
demonstrated collagen VIII synthesis and secretion in human macrophages that was 
decreased by IFN- and LPS treatment (97, 98). Collagen VIII is a short-chain, nonfibrillar 
collagen that forms unique hexagonal lattice structures and possesses both structural and 
signalling properties. Later, human macrophages were shown to secrete collagen VI, which 
forms beaded filaments with a multidomain structure that interact with ECMs and cell surface 
receptors to anchor interstitial structures and cells within tissues. Expression of collagen VI 
was decreased by IFN- and LPS, but increased upon IL-4 treatment (99). Recently, the 
expression of all 28 collagen-encoding mRNAs was quantified in steady-state and LPS-
activated primary human macrophages and compared to that of human dermal fibroblasts, 
an abundant matrix source (95). Steady-state macrophages expressed basal levels (lower 
than those in dermal fibroblasts) of collagen mRNAs with the exception of collagen III, X, XI, 
XVI, XX and XXVI. However, LPS specifically increased the expression of fibril-associated 
collagens with interrupted triple helices (FACITs; collagen VII, XII, XV, XIX and XXI), the 
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collagenase-resistant collagen V, the collagen-containing von Willebrand factor collagen 
XXVIII and collagen I, IV, XVIII, XXV and XXVII. Collagen II, VIII, IX, XIII, XIV, XXIII and 
XXIV expression was not increased. LPS also downregulated the expression of collagen VI, 
confirming previous studies (99), and collagen XIII and XVII (95).    By secreting collagens, 
depending upon their mode of activation, macrophages may contribute to the ECM and 
therefore tissue stabilization and repair and to cell-cell and cell-matrix interactions (e.g. in 
vitro, monocytes adhere strongly to collagen VI (99)). Furthermore, macrophages may bind 
to their secreted collagen molecules as they express several receptors known to interact 
with collagen (e.g. integrins and proteoglycans). However, collagen secretion by 
macrophages and its potential role in macrophage adhesion and immune response in vivo 
remain to be clarified. 
 
The ECM: an integral part of the innate immune response to infection? 
 
Antimicrobial activity of the ECM 
The innate immune system employs endogenous peptides like alpha-defensin and LL-37, 
which bind to heparin and dermatan sulphate glycosaminoglycans and have antimicrobial 
properties. During the inflammatory response to infection, tissue degrading enzymes 
generate bioactive ECM fragments. A number of studies showed that heparin-binding 
peptides derived from laminin isoforms, vitronectin, thrombospondin and fibronectin exert 
antimicrobial activities against gram-positive and gram-negative bacteria, and the fungus 
Candida albicans (100-102).     
 
Certain ECM proteins are also found in biological fluids. One such protein is tenascin-C, 
which has been found in human breast milk (2.2-671 g/ml) where it acts as an innate 
broad-spectrum HIV-1-neutralizing protein (103). Tenascin-C directly captures HIV-1 virions 
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by binding to the HIV-1 Envelope gp120 protein at a CD4-inducible epitope that overlaps the 
chemokine coreceptor binding site. Accordingly, tenascin-C depletion abolishes the HIV-1-
neutralizing activity of milk (103).     
 
Direct antimicrobial activity has also been reported for the ECM-associated protein MMP-12, 
which is abundantly expressed in mature tissue macrophages and mobilized to macrophage 
phagolysosomes after the ingestion of bacteria. Inside phagolysosomes, MMP-12 adheres to 
bacterial cell walls and disrupts cellular membranes, killing the bacteria. Notably, the C-
terminal domain of MMP-12, but not its catalytic domain, contains a four amino acid 
sequence on an exposed beta loop of the protein that is unique in nature and confers 
antimicrobial activity (104). Together, these data may help the search for safe, endogenous 
antimicrobial molecules from complex biological mixtures. Furthermore, binding epitopes 
could serve as templates for de novo synthesis of novel antimicrobial molecules. 
 
ECM-mediated recognition of microbial pathogens, macrophage activation and phagocytosis 
The innate immune system employs highly conserved receptors, namely pattern-recognition 
receptors (PRRs), to recognize conserved motifs in microbial pathogens, called pathogen-
associated molecular patterns (PAMPs). Mindin, a member of the mindin-F-spondin family of 
secreted ECM proteins, has emerged as a unique pattern-recognition molecule in the ECM 
for microbial pathogens and has been proposed to function as an integral part of the innate 
immune response (105). He et al., showed that genetic ablation of mindin confers resistance 
to LPS-induced shock and systemic S. typhimurium and S. pneumoniae infections in vivo. 
Moreover, mindin-null mice feature impaired bacterial clearance in lungs infected with gram-
positive group B streptococcus or H. influenza. In vitro, macrophages and mast cells lacking 
mindin display impaired TNF- and IL-6 production and defective phagocytosis. By using 
recombinant mindin, the authors showed that this ECM protein recognizes carbohydrate 
moieties of gram-positive and gram-negative bacterial components and, by binding to them, 
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it agglutinates bacteria. As glucose inhibited not only mind binding to pathogens but also 
macrophage activation by LPS, the authors concluded that mindin-mediated carbohydrate 
recognition of microbial pathogens is a secondary stimulation necessary for the activation of 
macrophages and mast cells (105) (Fig. 1). Notably, mindin is not a universal, but a rather 
specific pattern-recognition molecule as it only recognizes and opsonizes certain bacteria. 
Following this, the innate immune function of mindin has been extended to include promoting 
influenza virus clearance from the nasal cavity by allowing efficient macrophage activation 
(106). Furthermore, the proteoglycan lumican, whose core protein contains tandem repeats 
of leucine rich motifs similarly to PRRs, interacts with CD14 on the surface of macrophages 
and neutrophils, promoting CD14-TLR4-mediated responses to LPS (Fig. 1). Thus, lumican-
null mice are hypo responsive to LPS-induced septic shock (107). In a P. aeruginosa model 
of lung infection, mortality of lumican deficient mice is increased as animals fail to clear 
bacteria from tissues. This study showed that CD14-mediated phagocytosis of E. coli and P. 
aeruginosa bacteria by macrophages is impaired in the absence of lumican and identified 
Tyr-20 as a vital residue for CD14 binding and phagocytosis (108). Finally, infection of the 
cornea with P. aeruginosa readily increases lumican expression before inflammatory cell 
infiltration and lumican-null mice display poor resolution of bacterial keratitis and sustained 
production of pro-inflammatory cytokines (109). Another ECM protein that senses a number 
of microbial pathogens is galectin-3, which binds to carbohydrate structures on glycoproteins 
and glycolipids (e.g. N-acetyl-D-lactosamine and LPS) from (myco)bacteria, protozoan 
parasites and yeast (110). Although the in vivo function of galectin-3 during infection has not 
been fully investigated, upon microorganism recognition, it contributes to macrophage-
mediated phagocytosis, at least in vitro (111) (Fig. 1). Whether these ECM components 
exert the same essential immune functions in humans represents an outstanding, important 
question. 
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Leukocyte population balance in infection: emerging roles for ECM components 
Severe infection demands large numbers of leukocytes that is compensated by the 
emergency myelopoiesis response, which is initiated by activated PRRs and cytokines, 
including IL-6, GM-CSF and G-CSF. This protects the host from systemic infection by quickly 
generating the required leukocyte population. Kanayama et al. have recently found that 
osteopontin skewed the balance of myeloid and lymphoid cell populations during systemic 
infection with C. albicans (112). Specifically, the authors showed that osteopontin limited the 
supply of neutrophils and Ly6C+ monocytes-macrophages by enhancing the apoptosis of 
common myeloid and granulocyte-macrophage progenitors through a downregulation of the 
expression of the apoptosis inhibitor survivin. This resulted in greater fungal load in kidneys 
and significantly higher mortality of wild type mice with systemic fungal infection compared to 
osteopontin deficient littermates. The detrimental effect of osteopontin was observed early, 
24 hours post infection (112). However, it is unclear if this effect is maintained, exacerbated 
or reversed at later stages of infection.   
 
Dendritic cells (DCs) are the main antigen-presenting cells and, upon capturing microbial 
pathogens, mature and migrate to lymphoid tissues where they activate naïve T cells. 
Distinct classes of microbes elicit lineage-specific responses from the effector T cell 
repertoire. Helper T1 (Th1) cells are involved in infection by intracellular bacteria and 
viruses, Th2 cells in parasitic infection, and Th17 in infection by extracellular pathogens and 
facultative and obligate intracellular bacteria and fungi. Regulatory T cells (Tregs) hold the 
inflammatory response in check. Specific ECM proteins have been shown to contribute to 
the T cell polarizing function of DCs without affecting DC development. For instance, 
generation of Th17 cells by E. coli LPS or M. tuberculosis stimulated bone marrow-derived 
DCs from tenascin-C-null mice is significantly impaired (113). Furthermore, the expression of 
galectin-3 in DCs controls the magnitude of T cell priming in vitro and in vivo during 
helminthic infection with Schistosoma mansoni. Galectin-3 deficient mice have significantly 
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less T cells in their spleen and higher cellular and humoral Th1 responses (114). Although 
this study shows that galectin-3 expression by DCs modulates the proliferation and cytokine 
release by T cells, it does not explain the mechanism responsible for the biased Th1 
response. Efficient T cell priming by DCs has also been shown to depend on mindin (115). 
When DCs from mindin-null mice are activated with bacterial components, including LPS 
from Salmonella typhosa or E. coli and lipoteichoic acid from S. aureus, CD4+ T cell priming 
is 60-70% lower than that of wild type mice. Investigation of this demonstrated that DCs 
interact with mindin via integrins 41 and 51, leading to upregulated expression of the Rho 
GTPases Rac1/2, which are known to regulate DC priming of T cells (115). As DCs link 
innate to adaptive immunity and unbalanced effector T cell populations leads to pathological 
inflammation, understanding how the ECM can regulate T cell responses is crucial. 
 
Transcriptional and post-transcriptional roles for ECM molecules in host defense signalling 
pathways 
Pathogen recognition via PRRs initiates inflammatory signalling pathways which are tightly 
regulated to allow microbial clearance with minimal damage to the host. Recent research 
implicates a role for ECM and ECM-associated proteins in regulating inflammatory networks 
at the transcriptional and post-transcriptional level during the immune response to infection. 
 
An elegant study by Marchant el al. found a transcriptional role for MMP-12 (macrophage 
elastase) in immunity against viral infection (69). During coxackievirus type B3 and 
respiratory syncytial virus infections, MMP-12-null mice display increased viral load, mortality 
and lower levels of IFN-, which is essential for viral immunity. Mechanistically, secreted 
MMP-12 is taken up by virus-infected cells and traffics to the nucleus, where it binds to the 
NFKBIA promoter, driving its transcription, which is essential for optimal IFN- secretion and 
host protection. Additionally, MMP-12 regulates specific substrates by two distinct 
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mechanisms: 1) through DNA binding of gene exons (e.g. exons encoding PSME3, the 
immunoproteasome cap protein, and secreted protein acidic and rich in cysteine (SPARC)-
like protein 1, which decreases their mRNA and protein levels in MMP-12-null mice); and 2) 
extracellularly, through substrate protein cleavage (e.g. INF- receptor 2 binding site). Thus, 
MMP-12 clears systemic INF- and, accordingly, selective inhibition of extracellular MMP-12 
in infected wild type mice elevates systemic INF- levels and reduces viral replication (69).  
 
At the post-transcriptional level, a role for decorin and tenascin-C has been found in 
regulating miRNAs in LPS-induced sepsis (53, 93, 116). Merline et al. detected increased 
decorin levels in septic patients and mice with LPS-induced sepsis, and elevated IL-10 
amounts in decorin-null mice. They demonstrated that, in the presence of LPS, decorin 
reduces the levels of the anti-inflammatory cytokine IL-10 via two mechanisms. Firstly, it 
activates ERK and p38 MAP kinases downstream of TLR2 and TLR4 thereby inducing the 
expression of the pro-inflammatory modulator PDCD4 (programmed cell death 4), which 
translationally represses IL-10. Secondly, decorin inhibits TGF-1 signaling, leading to lower 
levels of miR-21, which represses PDCD4 expression and thus decreases IL-10 levels (93). 
Soon after, tenascin-C was shown to orchestrate the secretion of specific cytokine subsets in 
response to LPS. Specifically, tenascin-C regulates the biosynthesis of the LPS-responsive 
miRNA miR-155, allowing optimal TNF- production in macrophages and effective immune 
response to LPS in vivo (53). Thus, specific ECM and ECM-associated proteins possess 
previously unknown transcriptional and post-transcriptional regulatory activities, which fine-
tune the innate immune response to infection.  
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The ECM in infectious granulomas  
Tuberculosis, syphilis, toxoplasmosis, infectious mononucleosis and measles are a few 
examples of infectious diseases characterized by the formation of granulomas. Traditionally 
considered host-protective structures, infectious granulomas are compact, organised 
immune cell clusters that are generated in response to specific pathogens. Granulomas 
contain large numbers of mature macrophages, which can fuse into multinucleated giant 
cells or differentiate into foam cells. Neutrophils, dendritic cells, B, T and natural killer cells, 
and fibroblasts are also found in granulomas, which are surrounded by epithelial cells. 
Granulomas also contain ECM proteins, whose expression and function in infectious 
granulomatous disease pathogenesis has only recently been investigated.  
 
In humans, osteopontin has been detected in granulomas of diverse etiology (117) and, in 
those caused by Paracoccidioides brasiliensis, it localizes in ECM, macrophages and 
multinucleated giant cells at the center of lesions in the early phase of infection (118). In 
tuberculosis granulomas, osteopontin is markedly expressed within lymphocytes, 
macrophages, epithelioid cells and multinucleated giant cells, but not in the central necrotic 
core (54). These granulomas also stain strongly for tenascin-C in the surrounding fibrotic 
rings and weakly inside, in the ECM. A diffuse ECM-associated staining of galectin-9 is 
detected in the granuloma and in epithelioid and multinucleated giant cells. Notably, 
osteopontin, tenascin-C and galectin-9 are absent in non-infectious Crohn disease 
granulomas (54). Analysis of human lung biopsies from patients with atypical 
mycobacteriosis and tuberculosis revealed expression of tenascin-C and precursor proteins 
of collagens I and III around granulomas. Precursor proteins of collagen I were also found 
within granulomas that colocalized with myofibroblasts (119). In mice infected with P. 
brasiliensis, Gonzalez et al. detected increased expression of laminin, fibronectin, fibrinogen, 
collagen I, collagen III, elastic fibers and proteoglycans during granuloma formation (120). 
Analysis of their arrangement showed that they were mostly surrounding the granuloma, but 
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sporadically inside it. Initially arranged in a disorganised manner, ECM fibres later acquired a 
compact, concentric arrangement, which originated from an anchorage point that may 
contribute to tissue integrity and enhance distribution of growth factors and cytokines (120). 
Notably, during chronic mycobacterial infection, the fibrinolytic system has been shown to 
limit progressive fibrosis with plasminogen regulating the turnover of ECM proteins within the 
granuloma (121). 
 
Recent studies on ECM turnover in tuberculosis granuloma has helped rewrite tuberculosis 
immunopathology. Traditionally considered a host-protective structure that ‘quarantines’ the 
infecting mycobacteria, tuberculosis granuloma has been implicated in the expansion and 
dissemination of infection. Specifically, caseous necrosis leading to ECM destruction and 
bacterial dissemination was thought to be the cornerstone of tuberculosis pathogenesis. 
Conversely, collagen destruction has now been proposed to initiate caseous necrosis. 
Elkington et al. have first shown that MMP-1-expressing mice develop collagen destruction 
within granulomas upon infection with M. tuberculosis in the absence of caseous necrosis 
(122). They then demonstrated that proteolytic collagen destruction of the lung ECM is the 
initial pathological event that reduces the survival of M. tuberculosis-infected cells, resulting 
into caseous necrosis and cavitation, thus diverting the immune response in favour of the 
pathogen. Conversely, intact collagen fibrils increase survival of infected cells (123, 124). In 
line with this, Parasa et al. reported upregulation of MMP1, 3, 9 and 12 in a human lung 
tissue model and in biopsies from patients with non-cavitary tuberculosis. Global MMP 
inhibition via marimastat reduced granuloma formation and bacterial load (125).  
 
Future work should take into account the hypoxic conditions in infectious granulomas and 
include unbiased global analyses of ECM and ECM-associated molecules in granulomas at 
various disease stages and gain- and loss-of-function experiments in 3D systems and/or 
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genetically modified animals to understand the role of the ECM in granuloma formation and 
function. 
 
Concluding remarks and future perspectives 
The ECM and the innate immune response to infection are inextricably linked. Largely 
ignored or overlooked, the diverse yet specific functions of the ECM in infection influence the 
establishment and dissemination of microbial pathogens in host tissues as well as the 
outcome of the immune response to the infection (Fig. 2). In addition to the studies 
discussed here, ECM-immunological research, which is expanding into the areas of prion 
disease (126), virus transmission (127), exosomes in viral pathogenesis (128) and vaccine 
development (129), shows the breadth and complexity of ECM activity and regulation in 
infection. 
 
The ECM undergoes significant changes upon microbial invasion, magnifying the complexity 
of the cellular microenvironment at sites of infection. This presents challenges in setting up 
appropriate model systems and identifying the ECM and immunological pathways that are 
directly responsible for the outcome of individual infectious diseases. Unbiased omics, 
systems biology and genome editing approaches are promising resources for defining these 
pathways, designing mechanistic studies, and, in the longer-term, elucidating them in the 
context of the microbiota. 
 
As antimicrobial resistance is of global concern and tackling it is becoming increasingly 
challenging, investigating the now evident role of the ECM in infection may reveal novel 
therapeutic strategies or improve existing ones. It may also inform biomaterials and tissue 
engineering in their effort to prolong the lifespan and integrity of medical devices that are 
compromised by infection. 
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Figure legends 
 
Figure 1. Mindin, lumican and galectin-3: three extracellular sentinels. Mindin, lumican 
and galectin-3 recognize and bind to sugar moieties found in the cell wall of several types of 
bacteria. All of them promote phagocytosis of bacteria by macrophages. Mindin binds to 
bacteria, causes their opsonisation and agglutination, and facilitates their phagocytosis by 
macrophages. Mindin also induces the synthesis of proinflammatory cytokines by these 
cells. Lumican instead interacts with CD14 on the surface of macrophages, promoting CD14-
TLR4-mediated responses to LPS and CD14-mediated phagocytosis.  
 
Figure 2. Multiple functions of the ECM in the immune response to infection.  
Recognition of pathogen-associated molecular patterns by macrophages through PRRs and 
by ECM components is shown. Pathogen binding to ECM molecules such as fibronectin 
helps host colonization. Degradation of the ECM via microbial tissue degrading enzymes or 
host MMPs activated by pathogens facilitates host invasion. To establish the infection, 
pathogens can also hijack host proteolytic systems such as the plasminogen-plasmin system 
and evade innate immune responses by binding to ECM components such as vitronectin. 
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Fibroblasts in the interstitial ECM produce and secrete ECM proteins, MMPs and higher 
levels of LOX, which crosslinks collagen fibers, increasing ECM stiffness. Pathogen-
mediated activation of macrophages triggers inflammatory signalling pathways such as the 
NF-kB pathway, which culminates in the synthesis of cytokines, MMPs and miRNAs. 
Activated macrophages synthesize also ECM components such as decorin and tenascin-C, 
which regulate the biosynthesis of miR-21 and miR-155 and generate positive feedback 
loops that propagate inflammation. 
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Tables 
 
Table 1. Examples of specific host ECM-pathogen interactions that facilitate microbial 
adhesion to tissues and pathogenesis (* indicates that animal models of infection were used 
in the study)  
ECM molecule Pathogen Adhesin Effect of 
interaction 
Disease Referenc
e 
 
Fibronectin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma 
fibronectin 
 
 
 
Enterohemorrhagi
c 
Escherichia coli 
O157:H7 
 
 
 
Streptococcus 
pyogenes (group 
A streptococci, 
GAS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Staphylococcus 
aureus 
 
 
 
Salmonella 
typhimurium 
 
 
 
 
 
 
 
 
 
 
 
Borrelia 
burgdorferi 
 
Lpf 
fimbriae 
(LpfA1 
major 
subunit) 
 
Protein 
F1 
(functiona
l 
upstream 
domain) 
 
 
 
 
Protein 
F2 (C-
terminal 
domains) 
 
SfbII (C-
terminal 
domain) 
 
Fba 
 
 
 
MntC 
 
 
 
 
MisL (N-
terminal 
non-
conserve
d region) 
 
ShdA 
 
 
 
 
 
 
BBK32 
 
 
Colonization 
of GI tract 
 
 
 
 
Fibronectin 
links F1 to 
integrin 
receptors, 
helping 
bacterial 
uptake 
 
Host cell 
adhesion and 
internalization 
 
 
Host cell 
adhesion and 
internalization 
 
Host cell 
adhesion and 
internalization 
 
Mucosal 
colonization 
 
 
 
Intestinal 
colonization 
 
 
 
 
Binding to 
fibronectin 
13FnIII 
repeat 
module and 
intestinal 
colonization 
 
Fibronectin 
polymerizatio
n and 
 
Acute diarrhea; 
bloody diarrhea; 
hemolytic uremic 
syndrome 
 
 
 
Tonsillopharyngitis; 
necrotizing fasciitis; 
myositis; 
streptococcal toxic 
shock syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nosocomial 
infections,septicaemi
a, osteomyelitis, 
endocarditis, etc. 
 
Gastroenteritis 
 
 
 
 
 
 
 
 
 
 
 
 
Lyme disease 
 
 
(130) 
 
 
 
 
 
(131-133) 
 
 
 
 
 
 
 
(33) 
 
 
 
 
(134) 
 
 
 
(31) * 
 
 
 
(135) 
 
 
 
 
(136) * 
 
 
 
 
 
(137) 
 
 
 
 
 
 
(35) 
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Fibronectin N-
terminal 
proteolytic 
fragments (30 
and 70 kDa) 
 
Fibronectin N-
terminal 
proteolytic 
fragments (30, 
45 and 70 kDa) 
 
Laminin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collagen I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collagen II 
 
 
 
 
 
 
 
 
 
 
 
Streptococcus 
pyogenes  
 
 
 
 
Enterohemorrhagi
c 
Escherichia coli 
O157:H7 
 
 
 
Enterohemorrhagi
c 
Escherichia coli 
O157:H7 
 
 
 
Staphylococcus 
aureus 
 
 
 
Streptococcus 
gallolyticus 
(gallolyticus 
endocarditis 
isolates) 
 
Borrelia 
burgdorferi 
 
 
Streptococcus 
gallolyticus 
(gallolyticus 
endocarditis 
isolates) 
 
Salmonella 
typhimurium 
 
 
 
Enterococcus 
faecium 
 
 
 
 
Streptococcus 
gallolyticus 
(gallolyticus 
 
 
 
 
 
Protein 
F2 
(C-
terminal 
domains) 
 
 
Lpf 
fimbriae 
(LpfA1 
major 
subunit) 
 
Lpf 
fimbriae 
(LpfA1 
major 
subunit) 
 
MntC 
 
 
 
 
FimB, gtf 
and pilB 
 
 
 
 
ErpX 
 
 
 
FimB, gtf 
and pilB 
 
 
 
 
ShdA 
 
 
 
 
Pilus 
subunits 
EmpA 
and  
EmpB 
 
FimB, gtf 
and pilB 
 
 
colonization 
of vascular 
surfaces 
 
Eukaryotic 
cell adhesion 
and 
internalization 
 
 
 
Colonization 
of GI tract 
 
 
 
 
Colonization 
of GI tract 
 
 
 
 
Mucosal 
colonization 
 
 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
Long-term 
host tissue 
colonization 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
Intestinal 
colonization 
and 
persistence 
 
Adherence to 
host tissue 
and biofilm 
formation 
 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
 
 
 
 
Tonsillopharyngitis; 
necrotizing fasciitis; 
myositis; 
streptococcal toxic 
shock syndrome 
 
 
Acute diarrhea; 
bloody diarrhea; 
hemolytic uremic 
syndrome  
 
 
 
Acute diarrhea; 
bloody diarrhea; 
hemolytic uremic 
syndrome 
 
 
 
Nosocomial 
infections, 
septicaemia, 
osteomyelitis, 
endocarditis, etc. 
 
Infective endocarditis 
 
 
 
 
 
Lyme disease 
 
 
 
Infective endocarditis 
 
 
 
 
 
Gastroenteritis 
 
 
 
 
UTIs, bacteremia, 
and infective 
endocarditis 
 
 
 
 
 
 
 
(33) 
 
 
 
 
 
(130) 
 
 
 
 
 
(130) 
 
 
 
 
 
(135) 
 
 
 
 
(138) 
 
 
 
 
 
(139) 
 
 
 
(138) 
 
 
 
 
 
(137) 
 
 
 
 
(140) * 
 
 
 
 
 
(138) 
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Collagen IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collagen V 
 
 
 
 
Collagen VI 
 
 
 
 
Tenascin-C 
 
 
 
 
 
Vitronectin 
 
 
 
 
 
 
 
 
 
 
 
 
Thrombospondi
n 
 
 
 
Decorin 
 
 
endocarditis 
isolates) 
 
Enterohemorrhagi
c 
Escherichia coli 
O157:H7 
 
 
 
Staphylococcus 
aureus 
 
 
 
Streptococcus 
gallolyticus 
(gallolyticus 
endocarditis 
isolates) 
 
Salmonella 
typhimurium 
 
 
 
 
Enterococcus 
faecium 
 
 
 
Legionella 
pneumophila 
 
 
 
Streptococcus 
gallolyticus 
(gallolyticus 
endocarditis 
isolates) 
 
Streptococcus 
gallolyticus 
(gallolyticus 
endocarditis 
isolates) 
 
Yersinia 
enterocolitica 
 
 
 
 
 
Trypanosoma 
cruzi 
 
 
 
 
 
Lpf 
fimbriae 
(LpfA1 
major 
subunit) 
 
MntC 
 
 
 
 
FimB, gtf 
and pilB 
 
 
 
 
MisL (N-
terminal 
non-
conserve
d region) 
 
EcbA 
 
 
 
 
Mip 
 
 
 
 
FimB, gtf 
and pilB 
 
 
 
 
FimB, gtf 
and pilB 
 
 
 
 
YadA 
 
 
 
 
 
 
TcCRT 
 
 
 
DbpA 
 
 
Colonization 
of GI tract 
 
 
 
 
Mucosal 
colonization 
 
 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
Intestinal 
colonization 
 
 
 
 
Host tissue 
adhesion and 
biofilm 
formation 
 
Adhesion to 
lung tissue 
and bacterial 
dissemination 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
Adhesion and 
invasion of 
endothelial 
cells 
 
 
Adhesion to 
host cells and 
tissue; 
improved 
bacterial 
survival 
 
Enhancement  
of cellular 
infection 
 
Specific 
localization to 
Infective endocarditis 
 
 
 
 
 
 
Acute diarrhea; 
bloody diarrhea; 
hemolytic uremic 
syndrome 
 
 
 
Nosocomial 
infections,septicaemi
a, osteomyelitis, 
endocarditis, etc. 
 
Infective endocarditis 
 
 
 
 
 
Gastroenteritis 
 
 
 
 
 
UTIs, bacteremia, 
and infective 
endocarditis 
 
 
 
Legionellosis 
 
 
 
 
Infective endocarditis 
 
 
 
 
 
Infective endocarditis 
 
 
 
 
 
Enteric and systemic 
diseases 
 
 
 
 
(130) 
 
 
 
 
 
(135) 
 
 
 
 
(138) 
 
 
 
 
 
(136) * 
 
 
 
 
 
(141) 
 
 
 
 
(142) * 
 
 
 
 
(138) 
 
 
 
 
 
(138) 
 
 
 
 
 
(143) * 
 
 
 
 
 
 
(46) 
 
 
 
(144) * 
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Nidogen 1 and 
2 
 
 
 
 
Soluble and 
immobilized 
fibrinogen 
(alpha- and 
beta-chains)  
 
Borrelia 
burgdorferi 
 
 
 
 
 
 
 
 
 
 
Enterococcus 
faecium 
 
 
 
Staphylococcus 
aureus 
and 
DbpB 
 
 
 
 
 
 
 
 
 
 
SgrA 
 
 
 
 
ClfA, ClfB 
decorin-rich 
niches in the 
tunica 
adventitia 
and 
myocardial 
connective 
tissue; 
persistence 
of infection 
 
Host tissue 
adhesion and 
biofilm 
formation 
 
Colonization 
of biomaterial 
implants; 
bacterial 
spread 
 
Chagas disease 
 
 
 
Lyme disease 
 
 
 
 
 
 
 
 
 
 
 
UTIs, bacteremia, 
and infective 
endocarditis 
 
 
 
Nosocomial 
infections,septicaemi
a, osteomyelitis, 
endocarditis, etc. 
 
 
 
 
 
 
 
 
(141) 
 
 
 
 
(145, 146) 
GI: gastrointestinal; UTI: urinary tract infection; LpfAI: long polar fimbrae subunit 1; SfbII: 
fibronectin surface binding protein II; Fba: fibronectin binding protein; MntC: manganese 
transport protein C; MisL: autotransport protein MisL; FimB: type I fimbriae regulatory protein 
FimB; gtf: glucosyltransferase; pilB: type 4 fimbrial assembly protein; EcbA: E. faecium 
collagen binding protein A; MIP: macrophage infectivity potentiator; YadA: adhesin YadA; 
TcCRT: Trypanosoma cruzi calreticulin; DdpA/ DdpB: decorin binding protein A and B; SgrA: 
serine-glutamate repeat containing protein A; ClfA/ClfB: clumping factor A and B. 
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Table 2. Examples of specific ECM-pathogen interactions that facilitate host invasion 
through direct degradation of ECM components (* and # indicate that animal models of 
infection and ex vivo mammalian tissue degradation models, respectively, were used in the 
study) 
ECM 
molecule 
Pathogen Microbial 
enzyme 
Effect of ECM 
cleavage 
Disease Reference 
Laminin 
 
 
 
 
 
 
 
 
 
Collagen I 
 
 
 
 
 
 
Collagen I, 
II, III, IV, V 
and VI 
 
 
 
Collagen IV 
 
 
 
Fibronectin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vitronectin 
 
 
 
 
 
 
Tenascin-C 
(large 
Psedomonas 
aeruginosa 
 
 
 
Clostridium 
difficile  
 
 
 
Porphyromonas 
gingivalis 
 
 
Vibrio 
parahaemolyticus 
 
Clostridium 
histolyticum 
 
 
 
 
Streptococcus 
gordonii 
 
 
Clostridium 
difficile 
 
 
 
Porphyromonas 
gingivalis 
 
 
 
 
  
 
 
 
 
 
Clostridium 
difficile 
 
 
 
 
 
Porphyromonas 
gingivalis 
Elastase; alkaline 
protease 
 
 
 
Cwp84 
 
 
 
 
Gingipains in P. 
gingivalis 
supernatant 
 
Metalloprotease 
VppC 
 
Class I and II 
collagenases 
(ColG, ColH) 
 
 
 
Serine protease 
 
 
 
Cwp84 
 
 
 
 
Gingipains in P. 
gingivalis 
supernatant; 
HRgpA and 
RgpB gingipains 
 
 
 
 
 
 
 
Cwp84 
 
 
 
 
HRgpA, RgpB 
and Kgp 
gingipains 
Tissue invasion 
and necrosis 
 
 
 
Tissue integrity 
loss; facilitation 
of toxin 
diffusion 
 
Tissue 
degradation 
 
 
Tissue damage 
 
 
Necrotic tissue 
degradation; 
promote 
keratinocyte 
migration 
 
Basement 
membrane 
breakdown 
 
Tissue integrity 
loss; facilitation 
of toxin 
diffusion 
 
Cleavage and 
inactivation of 
cell-binding 
region of 
fibronectin; 
gingival 
fibroblast 
detachment 
and death; 
tissue 
destruction; 
 
Tissue integrity 
loss; facilitation 
of toxin 
diffusion 
 
 
Enhanced anti-
adhesive 
activity of 
Necrotizing 
pneumonia, septic 
shock, UTI, skin and 
soft tissue infections 
 
Pseudomembranous 
colitis and nosocomial 
diarrhea 
 
 
Periodontal disease 
 
 
 
Acute gastroenteritis 
 
 
Gas gangrene, 
infective endocarditis 
 
 
 
 
Infective endocarditis 
 
 
 
Pseudomembranous 
colitis and nosocomial 
diarrhea 
 
 
Periodontal disease 
 
 
 
 
 
 
 
 
 
 
 
Pseudomembranous 
colitis and nosocomial 
diarrhea 
 
 
 
 
Periodontal disease 
 
(147) # 
 
 
 
 
(148) 
 
 
 
 
(149) 
 
 
 
(150) 
 
 
(151, 152) 
 
 
 
 
 
(153) 
 
 
 
(148) 
 
 
 
 
(149, 154) 
# 
 
 
 
 
 
 
 
 
 
 
(148) 
 
 
 
 
 
 
(154) # 
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isoforms)  tenascin-C; 
gingival 
fibroblasts 
detachment, 
apoptosis and 
tissue 
destruction 
Cwp84: putative cell surface-associated cysteine protease; HRgpA and RgpB: arginine-
gingipains; Kgp: lysine-gingipains. 
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